MORPHINE Side Effects

6688167-6 | Parotitis
on Apr 16, 2010 Female patient from , 60 years of age, was diagnosed with postoperative analgesia, induction of anaesthesia, pain management and was treated with Morphine (View Usage). Patient experienced the following unwanted or unexpected effects: parotitis. Morphine dosage: . During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), SALICYLATE (View Salicylate Review and Salicylate Label ), FENTANYL (150 Mcg) (View Fentanyl Review and Fentanyl Label ), PROPOFOL (200 Mg) (View Propofol Review and Propofol Label ), VECURONIUM BROMIDE (10 Mg) (View Vecuronium Bromide Review and Vecuronium Bromide Label ).

6687307-2 | Depression, Hypersomnia, Mental Status Changes, Overdose, Sedation
Patient was taking Morphine (View Usage). Patient had the following side effects: depression (What is depression?), hypersomnia, mental status changes, overdose, sedation on Apr 16, 2010 from UNITED STATES Additional patient health information: Male patient , 57 years of age, weighting 216.1 lb, was diagnosed with back pain (What is back pain?) and. Morphine dosage: 15 Mg Bid Po. Patient was hospitalized.

6687015-8 | Anaesthetic Complication, Bradycardia, Oxygen Saturation Decreased, Procedural Hypotension, Respiratory Rate Decreased, Somnolence
Adverse event was reported on Apr 15, 2010 by a Male patient taking Morphine (View Usage) (Dosage: ) was diagnosed with nerve block, epidural test dose, resuscitation and. Location: , 78 years of age, After Morphine was administered, patient had the following side effects: anaesthetic complication, bradycardia, oxygen saturation decreased, procedural hypotension, respiratory rate decreased, somnolence. During the same period patient was treated with LIDOCAINE (View Lidocaine Review and Lidocaine Label ), BUPIVACAINE HCL (View Bupivacaine Hcl Review and Bupivacaine Hcl Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), EPINEPHRINE (View Epinephrine Review and Epinephrine Label ), RINGER'S (View Ringer's Review and Ringer's Label ), HETASTARCH IN SODIUM CHLORIDE (View Hetastarch In Sodium Chloride Review and Hetastarch In Sodium Chloride Label ), MEPHENTERMINE (View Mephentermine Review and Mephentermine Label ). Patient was hospitalized.

6686385-4 | Lung Abscess, Respiratory Distress, Sepsis, Tracheo-oesophageal Fistula
on Apr 15, 2010 Male patient from , 50 years of age, was diagnosed with dyspnoea, sedation, tracheal oedema and was treated with Morphine (View Usage). Patient experienced the following unwanted or unexpected effects: lung abscess, respiratory distress, sepsis (What is sepsis?), tracheo-oesophageal fistula. Morphine dosage: . During the same period patient was treated with DEXAMETHASONE (12 Mg) (View Dexamethasone Review and Dexamethasone Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ).


6684411-X | Dependence On Enabling Machine Or Device, Infection, Pain, Phantom Pain, Skin Ulcer
on Apr 13, 2010 Male patient from , 45 years of age, was diagnosed with complex regional pain syndrome (What is complex regional pain syndrome?), phantom pain and was treated with Morphine (View Usage). Patient had the following side effects: dependence on enabling machine or device, infection (What is infection?), pain (What is pain?), phantom pain, skin ulcer. Morphine dosage: 0.25 Mg. During the same period patient was treated with DIAZEPAM (5 Mg) (View Diazepam Review and Diazepam Label ), SERTRALINE HCL (50 Mg) (View Sertraline Hcl Review and Sertraline Hcl Label ), GABAPENTIN (600 Mg) (View Gabapentin Review and Gabapentin Label ), ROPIVACAINE HYDROCHLORIDE (View Ropivacaine Hydrochloride Review and Ropivacaine Hydrochloride Label ). Patient was hospitalized.

6684235-3 | Cardiac Failure, Constipation, Dehydration, Lymphoedema, Pleural Effusion
Patient was taking Morphine (View Usage). After Morphine was administered, patient had the following side effects: cardiac failure, constipation (What is constipation?), dehydration, lymphoedema, pleural effusion on Apr 14, 2010 from Additional patient health information: Male patient , 64 years of age, was diagnosed with arthralgia, hypertension, atrial fibrillation (What is atrial fibrillation?) and. Morphine dosage: . During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), DOXAZOSIN (View Doxazosin Review and Doxazosin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), BENDROFLUAZIDE (View Bendrofluazide Review and Bendrofluazide Label ).

6683430-7 | Respiratory Distress
Adverse event was reported on Apr 14, 2010 by a Male patient taking Morphine (View Usage) (Dosage: ) was diagnosed with pain (What is pain?) and. Location: , 62 years of age, Patient experienced the following unwanted or unexpected effects: respiratory distress. During the same period patient was treated with FENTANYL (View Fentanyl Review and Fentanyl Label ), BUPIVACAINE HCL (View Bupivacaine Hcl Review and Bupivacaine Hcl Label ).

6683380-6 | Dyspnoea
on Apr 14, 2010 Female patient from , 58 years of age, was diagnosed with dyspnoea and was treated with Morphine (View Usage). Patient had the following side effects: dyspnoea. Morphine dosage: .

6683305-3 | Weaning Failure
on Apr 12, 2010 Female patient from , 14 years of age, was diagnosed with anaesthesia, postoperative analgesia, induction of anaesthesia, neuromuscular blockade, maintenance of anaesthesia and was treated with Morphine (View Usage). After Morphine was administered, patient had the following side effects: weaning failure. Morphine dosage: . During the same period patient was treated with TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), ATROPINE (View Atropine Review and Atropine Label ), ISOFLURANE (View Isoflurane Review and Isoflurane Label ), NITROUS OXIDE (View Nitrous Oxide Review and Nitrous Oxide Label ).

6683282-5 | Weaning Failure
Patient was taking Morphine (View Usage). Patient experienced the following unwanted or unexpected effects: weaning failure on Apr 12, 2010 from Additional patient health information: Male patient , child 8 years of age, was diagnosed with anaesthesia, postoperative analgesia, induction of anaesthesia, neuromuscular blockade and. Morphine dosage: . During the same period patient was treated with TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), D TUBOCURARINE (View D-tubocurarine Review and D-tubocurarine Label ), MEPERIDINE HCL (View Meperidine Hcl Review and Meperidine Hcl Label ).

6683280-1 | Chest X-ray Abnormal, Cyanosis, Unresponsive To Stimuli
Adverse event was reported on Apr 12, 2010 by a Male patient taking Morphine (View Usage) (Dosage: ) was diagnosed with postoperative analgesia, induction of anaesthesia, neuromuscular blockade, maintenance of anaesthesia, neuromuscular blockade reversal and. Location: , 18 years of age, Patient had the following side effects: chest x-ray abnormal, cyanosis, unresponsive to stimuli. During the same period patient was treated with DIAZEPAM (View Diazepam Review and Diazepam Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), ATRACURIUM BESYLATE (View Atracurium Besylate Review and Atracurium Besylate Label ), ISOFLURANE (View Isoflurane Review and Isoflurane Label ), NITROUS OXIDE (View Nitrous Oxide Review and Nitrous Oxide Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), NEOSTIGMINE (View Neostigmine Review and Neostigmine Label ), ATROPINE (View Atropine Review and Atropine Label ).

6683183-2 | Weaning Failure
on Apr 12, 2010 Male patient from , child 5 years of age, was diagnosed with anaesthesia, postoperative analgesia, induction of anaesthesia, neuromuscular blockade, maintenance of anaesthesia and was treated with Morphine (View Usage). After Morphine was administered, patient had the following side effects: weaning failure. Morphine dosage: . During the same period patient was treated with SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), ATRACURIUM BESYLATE (View Atracurium Besylate Review and Atracurium Besylate Label ), HALOTHANE (View Halothane Review and Halothane Label ), ISOFLURANE (View Isoflurane Review and Isoflurane Label ), NITROUS OXIDE (View Nitrous Oxide Review and Nitrous Oxide Label ).

6682946-7 | Hypoxia
on Apr 12, 2010 Female patient from , child 7 years of age, was diagnosed with maintenance of anaesthesia, induction of anaesthesia, neuromuscular blockade and was treated with Morphine (View Usage). Patient experienced the following unwanted or unexpected effects: hypoxia. Morphine dosage: . During the same period patient was treated with PROPOFOL (View Propofol Review and Propofol Label ), ATRACURIUM BESYLATE (View Atracurium Besylate Review and Atracurium Besylate Label ), HALOTHANE (View Halothane Review and Halothane Label ), NITRIC OXIDE (View Nitric Oxide Review and Nitric Oxide Label ).

6679065-2 | Cachexia, Delirium, Diarrhoea, Hallucination, Metastases To Liver, Nausea, Pruritus
Patient was taking Morphine (View Usage). Patient had the following side effects: cachexia, delirium, diarrhoea, hallucination, metastases to liver, nausea (What is nausea?), pruritus on Apr 12, 2010 from Additional patient health information: Male patient , 73 years of age, was diagnosed with arthralgia, antiemetic supportive care and. Morphine dosage: . During the same period patient was treated with DIAMORPHINE (View Diamorphine Review and Diamorphine Label ), CYCLIZINE (View Cyclizine Review and Cyclizine Label ), HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), LEVOMEPROMAZINE (View Levomepromazine Review and Levomepromazine Label ). Patient was hospitalized.

6678876-7 | Bezoar, Intestinal Gangrene
Adverse event was reported on Apr 12, 2010 by a Female patient taking Morphine (View Usage) (Dosage: ) was diagnosed with pancreatitis and. Location: , 22 years of age, After Morphine was administered, patient had the following side effects: bezoar, intestinal gangrene. Patient was hospitalized.

6678624-0 | Lethargy, Mental Status Changes, Po2 Decreased, Unresponsive To Stimuli
on Apr 12, 2010 Female patient from UNITED STATES , 65 years of age, weighting 177.9 lb, was diagnosed with pain (What is pain?) and was treated with Morphine (View Usage). Patient experienced the following unwanted or unexpected effects: lethargy, mental status changes, po2 decreased, unresponsive to stimuli. Morphine dosage: 0/2/10 Pca. During the same period patient was treated with PERCOCET (5/325 Mg Po Q 4 Prn) (View Percocet Review and Percocet Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DOCUSATE (View Docusate Review and Docusate Label ), HYDRALAZINE HCL (View Hydralazine Hcl Review and Hydralazine Hcl Label ), INSULIN (View Insulin Review and Insulin Label ), LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), VANCOMYCIN HCL (View Vancomycin Hcl Review and Vancomycin Hcl Label ).

6677320-3 | Erythema, Swelling
on Apr 08, 2010 Female patient from UNITED STATES , 81 years of age, weighting 136.7 lb, was diagnosed with pain (What is pain?) and was treated with Morphine (View Usage). Patient had the following side effects: erythema, swelling. Morphine dosage: 1-2 Mg Every 2 According To Necessity Iv. During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), PREVACID (View Prevacid Review and Prevacid Label ), CELEBREX (View Celebrex Review and Celebrex Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), VITAMIN E (View Vitamin E Review and Vitamin E Label ).

6677318-5 | Injection Site Erythema, Pruritus
Patient was taking Morphine (View Usage). After Morphine was administered, patient had the following side effects: injection site erythema, pruritus on Apr 09, 2010 from UNITED STATES Additional patient health information: Female patient , 14 years of age, weighting 138.9 lb, was diagnosed with pain (What is pain?) and. Morphine dosage: 6 Mg X1 Iv. During the same period patient was treated with ZOFRAN (View Zofran Review and Zofran Label ).

6673861-3 | Brain Oedema, Pulmonary Oedema
Adverse event was reported on Mar 23, 2010 by a Male patient taking Morphine (View Usage) (Dosage: Parenteral) . Location: UNITED STATES , 50 years of age, Patient experienced the following unwanted or unexpected effects: brain oedema, pulmonary oedema.

6673860-1 | Scar
on Mar 23, 2010 Male patient from UNITED STATES , 47 years of age, weighting 204.0 lb, was treated with Morphine (View Usage). Patient had the following side effects: scar (What is scar?). Morphine dosage: . During the same period patient was treated with OXYCODONE AND ACETAMINOPHEN (View Oxycodone And Acetaminophen Review and Oxycodone And Acetaminophen Label ), FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ), CYCLOBENZAPRINE (View Cyclobenzaprine Review and Cyclobenzaprine Label ), DOXEPIN HCL (View Doxepin Hcl Review and Doxepin Hcl Label ), DIPHENHYDRAMINE HYDROCHLORIDE (View Diphenhydramine Hydrochloride Review and Diphenhydramine Hydrochloride Label ).

6673858-3 | Cardiomegaly, Pulmonary Oedema
on Mar 23, 2010 Female patient from UNITED STATES , 50 years of age, was treated with Morphine (View Usage). After Morphine was administered, patient had the following side effects: cardiomegaly, pulmonary oedema. Morphine dosage: Per Oral. During the same period patient was treated with ACETAMINOPHEN W/ PROPOXYPHENE HCL (Per Oral) (View Acetaminophen W/ Propoxyphene Hcl Review and Acetaminophen W/ Propoxyphene Hcl Label ), SERTRALINE HCL (Per Oral) (View Sertraline Hcl Review and Sertraline Hcl Label ), HYDROMORPHONE HCL (Per Oral) (View Hydromorphone Hcl Review and Hydromorphone Hcl Label ), HYDROCODONE BITARTRATE AND ACETAMINOPHEN (Per Oral) (View Hydrocodone Bitartrate And Acetaminophen Review and Hydrocodone Bitartrate And Acetaminophen Label ), ALPRAZOLAM (Per Oral) (View Alprazolam Review and Alprazolam Label ), MEPROBAMATE (Per Oral) (View Meprobamate Review and Meprobamate Label ), DIPHENHYDRAMINE HYDROCHLORIDE (Per Oral) (View Diphenhydramine Hydrochloride Review and Diphenhydramine Hydrochloride Label ), THC (View Thc Review and Thc Label ).

6673856-X | Alanine Aminotransferase Increased, Apnoea, Aspartate Aminotransferase Increased, Blood Amylase Increased, Blood Creatine Phosphokinase Increased, Blood Creatinine Increased, Blood Ph Decreased, Bradycardia, Cardiac Arrest
Patient was taking Morphine (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, apnoea, aspartate aminotransferase increased, blood amylase increased, blood creatine phosphokinase increased, blood creatinine increased, blood ph decreased, bradycardia, cardiac arrest (What is cardiac arrest?) on Mar 23, 2010 from UNITED STATES Additional patient health information: Female patient , 51 years of age, . Morphine dosage: . During the same period patient was treated with BENZODIAZEPINE (View Benzodiazepine Review and Benzodiazepine Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), VENLAFAXINE HCL (View Venlafaxine Hcl Review and Venlafaxine Hcl Label ), TRAZODONE (View Trazodone Review and Trazodone Label ). Patient was hospitalized.

6673855-8 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Atrial Fibrillation, Brain Oedema, Bronchitis Bacterial, Electroencephalogram Abnormal, Hepatic Congestion, Hepatic Necrosis
Adverse event was reported on Mar 23, 2010 by a Male patient taking Morphine (View Usage) (Dosage: Per Oral) . Location: UNITED STATES , 59 years of age, Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, atrial fibrillation (What is atrial fibrillation?), brain oedema, bronchitis bacterial, electroencephalogram abnormal, hepatic congestion, hepatic necrosis. During the same period patient was treated with HYDROCODONE BITARTRATE (Per Oral) (View Hydrocodone Bitartrate Review and Hydrocodone Bitartrate Label ), OXYCODONE HCL (Per Oral) (View Oxycodone Hcl Review and Oxycodone Hcl Label ), ALPRAZOLAM (Per Oral) (View Alprazolam Review and Alprazolam Label ), BUTALBITAL (Per Oral) (View Butalbital Review and Butalbital Label ), AMPHETAMINES (View Amphetamines Review and Amphetamines Label ), THC (View Thc Review and Thc Label ). Patient was hospitalized.

6673853-4 | Cardio-respiratory Arrest, Unresponsive To Stimuli
on Mar 23, 2010 Male patient from UNITED STATES , 47 years of age, was treated with Morphine (View Usage). After Morphine was administered, patient had the following side effects: cardio-respiratory arrest, unresponsive to stimuli. Morphine dosage: . During the same period patient was treated with DIAZEPAM (View Diazepam Review and Diazepam Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), SERTRALINE HCL (View Sertraline Hcl Review and Sertraline Hcl Label ).

6673838-8 | Cardiomegaly, Emphysema
on Mar 23, 2010 Male patient from UNITED STATES , 56 years of age, was treated with Morphine (View Usage). Patient experienced the following unwanted or unexpected effects: cardiomegaly, emphysema. Morphine dosage: . During the same period patient was treated with DIAZEPAM (View Diazepam Review and Diazepam Label ).

6673837-6 |
Patient was taking Morphine (View Usage). on Mar 23, 2010 from UNITED STATES Additional patient health information: Male patient , 55 years of age, weighting 167.0 lb, . Morphine dosage: Per Oral. During the same period patient was treated with ALPRAZOLAM (Per Oral) (View Alprazolam Review and Alprazolam Label ), ETHANOL (Per Oral) (View Ethanol Review and Ethanol Label ).

6673757-7 | Blood Ph Decreased, Completed Suicide, Hypotension, Incorrect Dose Administered, Renal Impairment, Respiratory Depression, Vomiting
Adverse event was reported on Mar 23, 2010 by a Female patient taking Morphine (View Usage) (Dosage: ) . Location: UNITED STATES , 81 years of age, After Morphine was administered, patient had the following side effects: blood ph decreased, completed suicide, hypotension, incorrect dose administered, renal impairment, respiratory depression, vomiting. During the same period patient was treated with DILTIAZEM (View Diltiazem Review and Diltiazem Label ), AMIODARONE (View Amiodarone Review and Amiodarone Label ), LABETALOL HCL (View Labetalol Hcl Review and Labetalol Hcl Label ), ACETAMINOPHEN AND HYDROCODONE BITARTRATE (View Acetaminophen And Hydrocodone Bitartrate Review and Acetaminophen And Hydrocodone Bitartrate Label ). Patient was hospitalized.

6673756-5 |
on Mar 23, 2010 Male patient from UNITED STATES , 50 years of age, was treated with Morphine (View Usage). . Morphine dosage: . During the same period patient was treated with OXYCODONE (View Oxycodone Review and Oxycodone Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), PHENTERMINE (View Phentermine Review and Phentermine Label ).

6673755-3 | Acute Hepatic Failure, Blood Pressure Decreased, Depressed Level Of Consciousness, Hypothermia, International Normalised Ratio Increased, Miosis, Multi-organ Failure, Suicide Attempt, Tachycardia
on Mar 23, 2010 Male patient from UNITED STATES , 53 years of age, was treated with Morphine (View Usage). Patient had the following side effects: acute hepatic failure, blood pressure decreased, depressed level of consciousness, hypothermia (What is hypothermia?), international normalised ratio increased, miosis, multi-organ failure, suicide attempt, tachycardia. Morphine dosage: . During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ), HYDROMORPHONE (View Hydromorphone Review and Hydromorphone Label ), CARISOPRODOL (View Carisoprodol Review and Carisoprodol Label ), DIPHENOXYLATE HCL + ATROPINE SULFATE (View Diphenoxylate Hcl + Atropine Sulfate Review and Diphenoxylate Hcl + Atropine Sulfate Label ). Patient was hospitalized.

6673754-1 |
Patient was taking Morphine (View Usage). on Mar 23, 2010 from UNITED STATES Additional patient health information: Male patient , 42 years of age, . Morphine dosage: . During the same period patient was treated with COCAINE (View Cocaine Review and Cocaine Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ).

6673753-X | Accidental Overdose
Adverse event was reported on Mar 23, 2010 by a Female patient taking Morphine (View Usage) (Dosage: ) . Location: UNITED STATES , 46 years of age, Patient experienced the following unwanted or unexpected effects: accidental overdose. During the same period patient was treated with COCAINE (View Cocaine Review and Cocaine Label ), METHADONE HCL (View Methadone Hcl Review and Methadone Hcl Label ), HYDROCODONE BITARTRATE (View Hydrocodone Bitartrate Review and Hydrocodone Bitartrate Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), NAPROXEN (View Naproxen Review and Naproxen Label ).

6673752-8 | Completed Suicide, Multi-organ Failure
on Mar 23, 2010 Male patient from UNITED STATES , 50 years of age, was treated with Morphine (View Usage). Patient had the following side effects: completed suicide, multi-organ failure. Morphine dosage: . During the same period patient was treated with CLONAZEPAM (View Clonazepam Review and Clonazepam Label ). Patient was hospitalized.

6673751-6 | Blood Pressure Diastolic Decreased, Bradycardia, Completed Suicide, Electrocardiogram Qt Prolonged, Heart Rate Decreased, Hypotension, No Therapeutic Response, Unresponsive To Stimuli
on Mar 23, 2010 Male patient from UNITED STATES , 59 years of age, was treated with Morphine (View Usage). After Morphine was administered, patient had the following side effects: blood pressure diastolic decreased, bradycardia, completed suicide, electrocardiogram qt prolonged, heart rate decreased, hypotension, no therapeutic response, unresponsive to stimuli. Morphine dosage: . During the same period patient was treated with DILTIAZEM (View Diltiazem Review and Diltiazem Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), ESOMEPRAZOLE (View Esomeprazole Review and Esomeprazole Label ), SOTALOL HCL (View Sotalol Hcl Review and Sotalol Hcl Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), HYDROMORPHONE (View Hydromorphone Review and Hydromorphone Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

6673750-4 | Aortic Arteriosclerosis, Arteriosclerosis Coronary Artery, Cardiomegaly, Coronary Artery Occlusion, Excoriation, Left Ventricular Hypertrophy
Patient was taking Morphine (View Usage). Patient experienced the following unwanted or unexpected effects: aortic arteriosclerosis, arteriosclerosis coronary artery, cardiomegaly, coronary artery occlusion, excoriation, left ventricular hypertrophy on Mar 23, 2010 from UNITED STATES Additional patient health information: Male patient , 46 years of age, weighting 161.0 lb, . Morphine dosage: . During the same period patient was treated with OXYCODONE (View Oxycodone Review and Oxycodone Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), TEMAZEPAM (View Temazepam Review and Temazepam Label ).

6673746-2 | Brain Oedema, Pulmonary Oedema
Adverse event was reported on Mar 23, 2010 by a Female patient taking Morphine (View Usage) (Dosage: Per Oral) . Location: UNITED STATES , 50 years of age, Patient had the following side effects: brain oedema, pulmonary oedema. During the same period patient was treated with METHADONE HCL (Per Oral) (View Methadone Hcl Review and Methadone Hcl Label ), COCAINE (Per Oral) (View Cocaine Review and Cocaine Label ), LORATADINE (Per Oral) (View Loratadine Review and Loratadine Label ).

6673745-0 | Cardio-respiratory Arrest, Jaundice, Multi-organ Failure
on Mar 23, 2010 Female patient from UNITED STATES , 70 years of age, weighting 147.0 lb, was treated with Morphine (View Usage). After Morphine was administered, patient had the following side effects: cardio-respiratory arrest, jaundice (What is jaundice?), multi-organ failure. Morphine dosage: Per Oral. During the same period patient was treated with TRAMADOL HCL (Per Oral) (View Tramadol Hcl Review and Tramadol Hcl Label ), DIPHENHYDRAMINE HYDROCHLORIDE (Per Oral) (View Diphenhydramine Hydrochloride Review and Diphenhydramine Hydrochloride Label ), LIDOCAINE (Per Oral) (View Lidocaine Review and Lidocaine Label ). Patient was hospitalized.

6673734-6 | Cardiomegaly, Completed Suicide, Coronary Artery Disease, Coronary Artery Stenosis, Myocardial Infarction, Overdose, Pulmonary Oedema
on Mar 23, 2010 Male patient from UNITED STATES , 53 years of age, was diagnosed with pain (What is pain?) and was treated with Morphine (View Usage). Patient experienced the following unwanted or unexpected effects: cardiomegaly, completed suicide, coronary artery disease (What is coronary artery disease?), coronary artery stenosis, myocardial infarction, overdose, pulmonary oedema. Morphine dosage: Per Oral.

6673733-4 |
Patient was taking Morphine (View Usage). on Mar 23, 2010 from UNITED STATES Additional patient health information: Female patient , 58 years of age, weighting 147.0 lb, . Morphine dosage: . During the same period patient was treated with ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), SECOBARBITAL SODIUM (View Secobarbital Sodium Review and Secobarbital Sodium Label ), CARISOPRODOL (View Carisoprodol Review and Carisoprodol Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), MEPROBAMATE (View Meprobamate Review and Meprobamate Label ).

6668297-5 | Ileus
Adverse event was reported on Apr 05, 2010 by a Male patient taking Morphine (View Usage) (Dosage: 30 Mg Bid Po) was diagnosed with pain (What is pain?) and. Location: UNITED STATES , 53 years of age, weighting 172.2 lb, After Morphine was administered, patient had the following side effects: ileus. Patient was hospitalized.

6663269-9 | Syncope
on Mar 31, 2010 Male patient from UNITED STATES , 86 years of age, was diagnosed with pain (What is pain?) and was treated with Morphine (View Usage). Patient experienced the following unwanted or unexpected effects: syncope. Morphine dosage: 2 Mg Once Iv.

6656652-9 | Hyperaesthesia
on Mar 15, 2010 Male patient from BULGARIA , 62 years of age, was diagnosed with pain (What is pain?), epilepsy (What is epilepsy?), laxative supportive care, wound treatment and was treated with Morphine (View Usage). Patient had the following side effects: hyperaesthesia. Morphine dosage: 15 Mg. During the same period patient was treated with DOLTARD (270 Mg/ 24 H (3 X 90 Mg)) (View Doltard Review and Doltard Label ), CARBAMAZEPINE (800 Mg / 24 H (200 + 200 + 400 Mg)) (View Carbamazepine Review and Carbamazepine Label ), SENNA MINT WAF (3 Tabs) (View Senna-mint Waf Review and Senna-mint Waf Label ), LACTULOSE (30 Ml) (View Lactulose Review and Lactulose Label ), METRONIDAZOLE (Unk) (View Metronidazole Review and Metronidazole Label ). Patient was hospitalized.

6651936-2 | Accidental Exposure, Confusional State, Excoriation, Headache, Nausea, Victim Of Sexual Abuse
Patient was taking Morphine (View Usage). After Morphine was administered, patient had the following side effects: accidental exposure, confusional state, excoriation, headache (What is headache?), nausea (What is nausea?), victim of sexual abuse on Mar 24, 2010 from Additional patient health information: Female patient , 24 years of age, . Morphine dosage: . During the same period patient was treated with GAMMA HYDROXYBUTYRATE (View Gamma-hydroxybutyrate Review and Gamma-hydroxybutyrate Label ).

6649795-7 | Unresponsive To Stimuli
Adverse event was reported on Mar 08, 2010 by a Male patient taking Morphine (View Usage) (Dosage: Per Oral) . Location: UNITED STATES , 36 years of age, Patient experienced the following unwanted or unexpected effects: unresponsive to stimuli. During the same period patient was treated with OXYCODONE (Per Oral) (View Oxycodone Review and Oxycodone Label ), HYDROCODONE BITARTRATE AND ACETAMINOPHEN (Per Oral) (View Hydrocodone Bitartrate And Acetaminophen Review and Hydrocodone Bitartrate And Acetaminophen Label ), DIPHENHYDRAMINE HYDROCHLORIDE (View Diphenhydramine Hydrochloride Review and Diphenhydramine Hydrochloride Label ), PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ), METHYLPHENIDATE (View Methylphenidate Review and Methylphenidate Label ), DEXTROMETHORPHAN (View Dextromethorphan Review and Dextromethorphan Label ).

6649764-7 | Cardiomegaly, Pulmonary Congestion, Pulmonary Oedema, Resuscitation, Skin Laceration, Unresponsive To Stimuli
on Mar 08, 2010 Male patient from UNITED STATES , 44 years of age, weighting 220.0 lb, was treated with Morphine (View Usage). Patient had the following side effects: cardiomegaly, pulmonary congestion, pulmonary oedema, resuscitation, skin laceration, unresponsive to stimuli. Morphine dosage: Per Oral. During the same period patient was treated with ALPRAZOLAM (Per Oral) (View Alprazolam Review and Alprazolam Label ), CYCLOBENZAPRINE (Per Oral) (View Cyclobenzaprine Review and Cyclobenzaprine Label ).

6649763-5 | Accident, Alcohol Poisoning, Fall, Pulmonary Congestion, Pulmonary Oedema
on Mar 08, 2010 Male patient from UNITED STATES , 38 years of age, weighting 290.0 lb, was treated with Morphine (View Usage). After Morphine was administered, patient had the following side effects: accident, alcohol poisoning, fall (What is fall?), pulmonary congestion, pulmonary oedema. Morphine dosage: Ingestion/parenteral. During the same period patient was treated with ETHANOL (Ingestion/parenteral) (View Ethanol Review and Ethanol Label ).

6649743-X | Hypoventilation, Lethargy
Patient was taking Morphine (View Usage). Patient experienced the following unwanted or unexpected effects: hypoventilation, lethargy on Mar 24, 2010 from UNITED STATES Additional patient health information: Female patient , 70 years of age, weighting 247.3 lb, . Morphine dosage: 15 Mg Tid Po.

6649366-2 | Body Temperature Increased, Completed Suicide, Hypotension, Pupil Fixed, Tachycardia, Unresponsive To Stimuli
Adverse event was reported on Mar 08, 2010 by a Female patient taking Morphine (View Usage) (Dosage: Per Oral) . Location: UNITED STATES , 44 years of age, Patient had the following side effects: body temperature increased, completed suicide, hypotension, pupil fixed, tachycardia, unresponsive to stimuli. During the same period patient was treated with TRAZODONE HCL (Per Oral) (View Trazodone Hcl Review and Trazodone Hcl Label ), THC (View Thc Review and Thc Label ). Patient was hospitalized.

6649362-5 | Cardiac Hypertrophy, Hepatic Congestion, Hepatic Steatosis, Pulmonary Congestion, Pulmonary Oedema, Respiratory Failure
on Mar 08, 2010 Female patient from UNITED STATES , 37 years of age, weighting 433.0 lb, was treated with Morphine (View Usage). After Morphine was administered, patient had the following side effects: cardiac hypertrophy, hepatic congestion, hepatic steatosis, pulmonary congestion, pulmonary oedema, respiratory failure. Morphine dosage: Per Oral. During the same period patient was treated with METHADONE HCL (Per Oral) (View Methadone Hcl Review and Methadone Hcl Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ).

6649216-4 | Unresponsive To Stimuli
on Mar 08, 2010 Female patient from UNITED STATES , 37 years of age, weighting 240.0 lb, was treated with Morphine (View Usage). Patient experienced the following unwanted or unexpected effects: unresponsive to stimuli. Morphine dosage: Per Oral. During the same period patient was treated with ALPRAZOLAM (Per Oral) (View Alprazolam Review and Alprazolam Label ), CITALOPRAM HYDROBROMIDE (Per Oral) (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), CYCLOBENZAPRINE (Per Oral) (View Cyclobenzaprine Review and Cyclobenzaprine Label ).

6647913-8 | Cerebrovascular Accident
Patient was taking Morphine (View Usage). Patient had the following side effects: cerebrovascular accident on Mar 16, 2010 from AUSTRIA Additional patient health information: Female patient , 38 years of age, . Morphine dosage: .